Wall Street Journal : Skincare Company Galderma Sees Opportunity in ‘Ozempic Face’

 

#Business #WallStreet

Speedy weight loss from drugs used to fight obesity and diabetes has left some users looking gaunt and aged. The boss of Swiss skincare group Galderma thinks treatments for what has been dubbed “Ozempic face” could give the company a lift.

Read More  

WSJ.com: US Business  

PAID 

This is a business article located in the U.S. Business section of the Wall Street Journal. For the latest articles on U.S. business, current markets and other business related news follow our Twitter Page or bookmark this website.

Leave a Reply

Generated by Feedzy